Newtopia Inc., a health technology company, operates a habit change platform. More Details
Adequate balance sheet and slightly overvalued.
Share Price & News
How has Newtopia's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NEWU is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: NEWU's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
7 Day Return
CA Healthcare Services
1 Year Return
CA Healthcare Services
Return vs Industry: NEWU underperformed the Canadian Healthcare Services industry which returned 105.2% over the past year.
Return vs Market: NEWU underperformed the Canadian Market which returned 36.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Newtopia's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Newtopia undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NEWU (CA$0.43) is trading below our estimate of fair value (CA$1.32)
Significantly Below Fair Value: NEWU is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NEWU is unprofitable, so we can't compare its PE Ratio to the North American Healthcare Services industry average.
PE vs Market: NEWU is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NEWU's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NEWU is overvalued based on its PB Ratio (10.2x) compared to the CA Healthcare Services industry average (8.3x).
How is Newtopia forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NEWU's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if NEWU's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NEWU's revenue (18.7% per year) is forecast to grow faster than the Canadian market (6.5% per year).
High Growth Revenue: NEWU's revenue (18.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NEWU's Return on Equity is forecast to be high in 3 years time
How has Newtopia performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: NEWU is currently unprofitable.
Growing Profit Margin: NEWU is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NEWU's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare NEWU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEWU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (18.1%).
Return on Equity
High ROE: NEWU has a negative Return on Equity (-184.1%), as it is currently unprofitable.
How is Newtopia's financial position?
Financial Position Analysis
Short Term Liabilities: NEWU's short term assets (CA$7.1M) exceed its short term liabilities (CA$3.0M).
Long Term Liabilities: NEWU's short term assets (CA$7.1M) exceed its long term liabilities (CA$667.6K).
Debt to Equity History and Analysis
Debt Level: NEWU is debt free.
Reducing Debt: NEWU had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NEWU has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NEWU has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Newtopia current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NEWU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NEWU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NEWU's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NEWU's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NEWU's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Jeffrey Ruby, also known as Jeff, J.D., MBA serves as Director at Newtopia Inc. since May 27, 2020. Mr. Ruby is the Founder and Chief Executive Officer of Newtopia Inc. Mr. Ruby is a health innovator w...
CEO Compensation Analysis
Compensation vs Market: Jeff's total compensation ($USD248.00K) is above average for companies of similar size in the Canadian market ($USD156.15K).
Compensation vs Earnings: Insufficient data to compare Jeff's compensation with company performance.
Experienced Management: NEWU's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Experienced Board: NEWU's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.
Newtopia Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Newtopia Inc.
- Ticker: NEWU
- Exchange: TSXV
- Founded: 2008
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: CA$42.207m
- Shares outstanding: 100.49m
- Website: https://www.newtopia.com
Number of Employees
- Newtopia Inc.
- 4101 Yonge Street
- Suite 706
- M2P 1N6
Newtopia Inc., a health technology company, operates a habit change platform. It offers a personalized habit change platform that focuses on metabolic risk reduction by developing and implementing personal...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/12 22:32|
|End of Day Share Price||2021/05/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.